| Class | Crystalloid fluid |
|---|---|
| Chemistry |
Isotonic disaccharide solution |
| Routes of administration |
IV only, though theoretically also orally |
| Absorption |
100% oral bioavailability; well absorbed |
| Solubility |
pKa = 12.9; good water solubility; in solution the dextrose is in an non-ionised state |
| Distribution |
VOD =0.6L/kg, distributed widely into total body water |
| Metabolism |
Metabolised extensively by all body tissues, but especially by the liver |
| Elimination |
Metabolites are water and CO2, which are eliminated by the kidneys and lungs, respectively |
| Time course of action |
"Half-life" of the volume expansion effect is perhaps 15-20 minutes in healthy volunteers. Dextrose itself |
| Target receptor |
GLUT family of glucose transporter proteins |
| Mechanism of action |
Expands the extracellular fluid volume and changes the biochemistry of the body fluids |
| Clinical effects |
Volume expansion: |
| Literature reference |
Griffel and Kaufman (1992) |
| CICM details of understanding | Level 1 |
| Mentioned around Deranged Physiology |
Solutions of dextrose: 5%, 10% and 50% concentrations; also Response to 1L of 5% dextrose. Affiliated with Control of blood glucose and therefore Pharmacology of insulin preparations and glucagon. |
| Related SAQs |